Takahiro Ito

11PUBLICATIONS
15CO-AUTHORS
Nutritional epidemiologyPredictive and prognostic markersRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2026
Long-term drug persistence and clinical outcomes of ustekinumab in Crohn's disease: a multicenter real-world study from the Hokkaido phoenix cohort.

|Jun 15, 2026
Long-term treatment outcomes of upadacitinib for Crohn's disease: a single-center retrospective study.

|Feb 25, 2026
Utility of Hybrid Endoscopy Combining Small-Bowel Capsule Endoscopy and Conventional Ileocolonoscopy in Crohn's Disease.

Takahiro Ito, Kohei Matsunaga, Yuya Ohno

|Feb 03, 2026
Association of tissue lymphocyte immunophenotype and clinical outcomes: A prospective study in patients with ulcerative colitis treated with vedolizumab.

Katsuyoshi Ando, Shin Kashima, Aki Sakatani

|Feb 03, 2026
Association of Proton Pump Inhibitor and Potassium-Competitive Acid Blocker Use With Discontinuation and Intolerance of Oral 5-Aminosalicylic Acid in Patients With Ulcerative Colitis.

Shinsuke Otagiri, Takahiro Ito, Keiji Yagisawa

|Jan 17, 2026
Intestinal transcriptomic analysis and prediction of biomarkers associated with mucosal healing following vedolizumab treatment in ulcerative colitis using machine learning.

Katsuyoshi Ando, Shin Kashima, Aki Sakatani

Pageof 2

Frequent Collaborators

4 joint publications

Mikihiro Fujiya

3 joint publications

Katsuyoshi Ando

3 joint publications

Atsuo Maemoto

2 joint publications

Hiroshi Nakase